Sangamo Therapeutics (SGMOQ) Goodwill (2013 - 2022)

Sangamo Therapeutics has reported Goodwill for 10 years, with the latest figure at $37.6 million in Q4 2022.

• On a quarterly basis, Goodwill fell 5.42% year-over-year to $37.6 million in Q4 2022; TTM through Dec 2022 was $37.6 million, a 5.42% decrease from a year earlier, with the FY2022 full-year figure at $37.6 million, down 5.42% from the prior year.
• Goodwill was $37.6 million for Q4 2022 at Sangamo Therapeutics, up from $34.5 million in the prior quarter.
• The five-year high for Goodwill was $42.8 million in Q4 2020, with the low at $1.6 million in Q1 2018.
• Average Goodwill over 5 years is $33.7 million, with a median of $39.3 million recorded in 2019.
• The sharpest annual moves came in 2018 and 2022: Goodwill jumped 2426.44% in 2018, then slipped 14.85% in 2022.
• Over 5 years, Goodwill stood at $40.0 million in 2018, then decreased by 1.93% to $39.3 million in 2019, then gained by 8.98% to $42.8 million in 2020, then slipped by 7.23% to $39.7 million in 2021, then slipped by 5.42% to $37.6 million in 2022.
• The last three Goodwill figures came in at $37.6 million (Q4 2022), $34.5 million (Q3 2022), and $36.7 million (Q2 2022), per Business Quant data.